Gary Ingenito
Director Técnico/Científico/I+D en CATALYST PHARMACEUTICALS, INC. .
Fortuna: 841 296 $ al 30/04/2024
Cargos activos de Gary Ingenito
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/06/2015 | - |
Consejero General | - | - |
Historial de carrera de Gary Ingenito
Antiguos cargos conocidos de Gary Ingenito.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Director Técnico/Científico/I+D | 01/02/2005 | 29/02/2008 |
Consejero General | 01/02/2005 | 29/02/2008 | |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/10/2003 | 01/01/2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Consejero General | - | - |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - | - |
ONTRAK, INC. | Director Técnico/Científico/I+D | 11/04/2011 | - |
Formación de Gary Ingenito.
Thomas Jefferson University | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Sidney Kimmel Medical College | Doctorate Degree |
University of Miami | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 10 |
Canadá | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Sectorial
Consumer Services | 5 |
Health Technology | 4 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ONTRAK, INC. | Health Services |
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Sandoz Pharmaceuticals Corp. | |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Gary Ingenito
- Experiencia